CEE VC SUMMIT 2026

Mabylon AG raises €31.8M
12 August 2025·2 min read

Joy Laoun

News Editor, Vestbee

Swiss biotech firm Mabylon AG raises €31.8M to advance peanut allergy antibody MY006

Deals#News#Switzerland

Joy Laoun

News Editor, Vestbee

Editor's pick
Aug 12VC funding in CEE report — Q2 2025
Aug 07Most common pitch deck mistakes, according to VCs
Jul 23 Promising climate tech startups to watch, according to investors
Jun 26List of new VC funds launched in Q2 2025 to invest in Europe
Jun 11Europe’s defence tech moment: why CEE can’t afford to lag behind
Explore more
Newsletter
Related posts
Explore more
German SaaS startup Plancraft secures €38M Series B led by Headline

The Series B round was led by Headline, with support from Creandum, HTGF, and xdeck.

London-based gametech startup TILKI raises $2.2M led by Twin Path Ventures

The pre-seed round was led by Twin Path Ventures, with participation from Atlas AI^VB Fund I, XTX Ventures, and SFC Capital.

Swedish energy tech firm Aira secures €150M to drive heating electrification across Europe

Aira secured €150 million in equity financing from existing investors, including Altor, Kallskär, Kinnevik, Lingotto, and Temasek.

Latest news
Explore more
German SaaS startup Plancraft secures €38M Series B led by Headline

The Series B round was led by Headline, with support from Creandum, HTGF, and xdeck.

VC of the month — BrightCap Ventures

Elina Halatcheva from BrightCap Ventures told Vestbee about the fund’s strategy and investment approach.

London-based gametech startup TILKI raises $2.2M led by Twin Path Ventures

The pre-seed round was led by Twin Path Ventures, with participation from Atlas AI^VB Fund I, XTX Ventures, and SFC Capital.

Subscribe to our newsletter
Join Vestbee
Join the leading matchmaking platform for startups, VC funds, angels, accelerators and corporates
Join Now